Skip to main content
Erschienen in: AIDS and Behavior 7/2017

17.02.2017 | Original Paper

Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care

verfasst von: Aaron M. Kipp, Peter F. Rebeiro, Bryan E. Shepherd, Lauren Brinkley-Rubinstein, Megan Turner, Sally Bebawy, Timothy R. Sterling, Todd Hulgan

Erschienen in: AIDS and Behavior | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

We assessed the association between marijuana use and retention in HIV care through a retrospective cohort study of patients engaged in care at a large HIV clinic in 2011 and 2012. Two different retention outcomes were assessed: not meeting the Institute of Medicine’s (IOM) retention definition (≥2 provider visits ≥90 days apart in a calendar year) and no-show visits. Any marijuana use and frequency of marijuana use were obtained from a substance use screening questionnaire administered at each clinic visit. Modified Poisson regression was used to estimate risk ratios and 95% confidence intervals for the association between marijuana use and retention outcomes. Marijuana use was reported by 17% of 1791 patients and 21% were not retained (IOM definition). Marijuana use was not associated with the IOM retention outcome, but was associated with missing the next scheduled appointment. A non-linear dose–response was observed for frequency of marijuana use and missed visits, with daily users having the highest risk compared to non-users. Daily marijuana use had a negative impact on HIV clinic attendance. Further research is needed to elucidate the mechanisms by which marijuana use affects this outcome to inform targeted interventions.
Literatur
2.
Zurück zum Zitat Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. HHS Publication No. SMA 16-4984, NSDUH Series H-51. Rockville, MD: Substance Abuse and Mental Health Services Adminstration. 2016. http://www.samhsa.gov/data. Accessed Nov 2016. Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. HHS Publication No. SMA 16-4984, NSDUH Series H-51. Rockville, MD: Substance Abuse and Mental Health Services Adminstration. 2016. http://​www.​samhsa.​gov/​data. Accessed Nov 2016.
3.
Zurück zum Zitat Kipp AM, Desruisseau AJ, Qian HZ. Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. J Subst Abuse Treat. 2011;40(4):386–96.CrossRefPubMedPubMedCentral Kipp AM, Desruisseau AJ, Qian HZ. Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. J Subst Abuse Treat. 2011;40(4):386–96.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2009. Morb Mortal Wkly Rep 2014;63(SS-5):1–22. Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2009. Morb Mortal Wkly Rep 2014;63(SS-5):1–22.
5.
Zurück zum Zitat Allshouse AA, MaWhinney S, Jankowski CM, Kohrt WM, Campbell TB, Erlandson KM. The impact of marijuana use on the successful aging of HIV-infected adults. J Acquir Immune Defic Syndr. 2015;69(2):187–92.CrossRefPubMedPubMedCentral Allshouse AA, MaWhinney S, Jankowski CM, Kohrt WM, Campbell TB, Erlandson KM. The impact of marijuana use on the successful aging of HIV-infected adults. J Acquir Immune Defic Syndr. 2015;69(2):187–92.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentral Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat D’Souza G, Matson PA, Grady CD, et al. Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Study (WIHS) Cohort, 1994–2010. J Acquir Immune Defic Syndr. 2012;61:618–26.CrossRefPubMedPubMedCentral D’Souza G, Matson PA, Grady CD, et al. Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Study (WIHS) Cohort, 1994–2010. J Acquir Immune Defic Syndr. 2012;61:618–26.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;371(9):879.PubMed Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;371(9):879.PubMed
9.
Zurück zum Zitat Van Tieu H, Koblin BA. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS. 2009;4(4):314–8.CrossRefPubMed Van Tieu H, Koblin BA. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS. 2009;4(4):314–8.CrossRefPubMed
10.
Zurück zum Zitat Kingree JB, Betz H. Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners. Drug Alcohol Depend. 2003;72(2):197–203.CrossRefPubMed Kingree JB, Betz H. Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners. Drug Alcohol Depend. 2003;72(2):197–203.CrossRefPubMed
11.
Zurück zum Zitat Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556–69.CrossRefPubMed Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556–69.CrossRefPubMed
12.
13.
Zurück zum Zitat Parolaro D, Vigano D, Realini N, Rubino T. Role of endocannabinoids in regulating drug dependence. Neuropsychiatr Dis Treat. 2007;3(6):711–21.PubMedPubMedCentral Parolaro D, Vigano D, Realini N, Rubino T. Role of endocannabinoids in regulating drug dependence. Neuropsychiatr Dis Treat. 2007;3(6):711–21.PubMedPubMedCentral
14.
Zurück zum Zitat Corless IB, Lindgren T, Holzemer W, et al. Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res. 2009;18(2):172–93.CrossRefPubMed Corless IB, Lindgren T, Holzemer W, et al. Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res. 2009;18(2):172–93.CrossRefPubMed
15.
Zurück zum Zitat Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs. 2004;18:215–28.CrossRefPubMed Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs. 2004;18:215–28.CrossRefPubMed
16.
Zurück zum Zitat Braitstein P, Kendall T, Chan K, et al. Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS. 2001;15:532–3.CrossRefPubMed Braitstein P, Kendall T, Chan K, et al. Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS. 2001;15:532–3.CrossRefPubMed
17.
Zurück zum Zitat Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manag. 2005;29:358–67.CrossRef Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manag. 2005;29:358–67.CrossRef
18.
Zurück zum Zitat Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr. 2004;35:38–45.CrossRefPubMed Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr. 2004;35:38–45.CrossRefPubMed
19.
20.
Zurück zum Zitat Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE. 2010;5(12):e14433.CrossRefPubMedPubMedCentral Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE. 2010;5(12):e14433.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–80.CrossRefPubMed Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–80.CrossRefPubMed
22.
Zurück zum Zitat Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2014;37(1):1–10.CrossRefPubMed Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2014;37(1):1–10.CrossRefPubMed
23.
Zurück zum Zitat Rosen MI, Black AC, Arnsten JH, et al. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav. 2013;17(1):142–7.CrossRefPubMedPubMedCentral Rosen MI, Black AC, Arnsten JH, et al. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav. 2013;17(1):142–7.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005;38:43–6.CrossRefPubMed de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005;38:43–6.CrossRefPubMed
25.
Zurück zum Zitat Ghosn J, Leruez-Ville M, Blanche J, et al. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Clin Infect Dis. 2014;58(12):1763–70.CrossRefPubMed Ghosn J, Leruez-Ville M, Blanche J, et al. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Clin Infect Dis. 2014;58(12):1763–70.CrossRefPubMed
26.
Zurück zum Zitat Milloy MJ, Marshall B, Kerr T, et al. High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Review. 2015;34(2):135–40.CrossRefPubMed Milloy MJ, Marshall B, Kerr T, et al. High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Review. 2015;34(2):135–40.CrossRefPubMed
27.
Zurück zum Zitat Abrams DI, Hilton JF, Leiser RJ, et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003;139(4):258–66.CrossRefPubMed Abrams DI, Hilton JF, Leiser RJ, et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003;139(4):258–66.CrossRefPubMed
28.
Zurück zum Zitat Rasbach DA, Desruisseau AJ, Kipp AM, et al. Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care. 2013;25(1):109–17.CrossRefPubMed Rasbach DA, Desruisseau AJ, Kipp AM, et al. Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care. 2013;25(1):109–17.CrossRefPubMed
29.
Zurück zum Zitat Dietz E, Clum GA, Chung SE, et al. Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health. 2010;46(3):278–83.CrossRefPubMed Dietz E, Clum GA, Chung SE, et al. Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health. 2010;46(3):278–83.CrossRefPubMed
30.
Zurück zum Zitat Weber R, Huber M, Battegay M, et al. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Med. 2015;16(3):137–51.CrossRefPubMed Weber R, Huber M, Battegay M, et al. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Med. 2015;16(3):137–51.CrossRefPubMed
31.
Zurück zum Zitat Morgan E, Khanna AS, Skaathun B, et al. Marijuana use among young black men who have sex with men and the HIV care continuum: findings from the uConnect Cohort. Subst Use Misuse. 2016;51(13):1751–9.CrossRefPubMed Morgan E, Khanna AS, Skaathun B, et al. Marijuana use among young black men who have sex with men and the HIV care continuum: findings from the uConnect Cohort. Subst Use Misuse. 2016;51(13):1751–9.CrossRefPubMed
32.
Zurück zum Zitat Ford MA, Spicer CM. Monitoring HIV care in the United States: indicators and data systems. Washington, DC: National Academies Press; 2012. Ford MA, Spicer CM. Monitoring HIV care in the United States: indicators and data systems. Washington, DC: National Academies Press; 2012.
33.
Zurück zum Zitat Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661–70.CrossRefPubMed Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661–70.CrossRefPubMed
34.
Zurück zum Zitat Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.CrossRefPubMedPubMedCentral Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Mugavero MJ, Westfall AO, Zinski A, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61(5):574–80.CrossRefPubMedPubMedCentral Mugavero MJ, Westfall AO, Zinski A, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61(5):574–80.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61(2):164–70.CrossRefPubMedPubMedCentral Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61(2):164–70.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.CrossRefPubMedPubMedCentral Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Monroe AK, Lau B, Mugavero MJ, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016;73(4):419–25.CrossRefPubMed Monroe AK, Lau B, Mugavero MJ, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016;73(4):419–25.CrossRefPubMed
39.
Zurück zum Zitat Chitsaz E, Meyer JP, Krishnan A, et al. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013;17(Suppl 2):S118–27.CrossRefPubMed Chitsaz E, Meyer JP, Krishnan A, et al. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013;17(Suppl 2):S118–27.CrossRefPubMed
40.
Zurück zum Zitat Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis. 2013;57(9):1309–17.CrossRefPubMedPubMedCentral Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis. 2013;57(9):1309–17.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat German D, Latkin CA. Social stability and health: exploring multidimensional social disadvantage. J Urban Health. 2012;89(1):19–35.CrossRefPubMed German D, Latkin CA. Social stability and health: exploring multidimensional social disadvantage. J Urban Health. 2012;89(1):19–35.CrossRefPubMed
42.
Zurück zum Zitat Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16(5):156–61.PubMed Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16(5):156–61.PubMed
43.
Zurück zum Zitat Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12–6.PubMed Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12–6.PubMed
44.
Zurück zum Zitat Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;15(31 Suppl 3):S149–53.CrossRef Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;15(31 Suppl 3):S149–53.CrossRef
45.
Zurück zum Zitat Hightow-Weidman LB, Jones K, Wohl AR, et al. Early linkage and retention in care: findings from the outreach, linkage, and retention in care initiative among young men of color who have sex with men. AIDS Patient Care STDS. 2011;25(Suppl 1):S31–8.CrossRefPubMed Hightow-Weidman LB, Jones K, Wohl AR, et al. Early linkage and retention in care: findings from the outreach, linkage, and retention in care initiative among young men of color who have sex with men. AIDS Patient Care STDS. 2011;25(Suppl 1):S31–8.CrossRefPubMed
46.
Zurück zum Zitat Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62(10):2420–33.CrossRefPubMed Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62(10):2420–33.CrossRefPubMed
47.
Zurück zum Zitat Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Int Med. 2016;176(3):352–61.CrossRef Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Int Med. 2016;176(3):352–61.CrossRef
48.
Zurück zum Zitat Schroder KE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV/AIDS Rep. 2009;6(4):210–6.CrossRefPubMed Schroder KE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV/AIDS Rep. 2009;6(4):210–6.CrossRefPubMed
49.
Zurück zum Zitat Tucker JA, Simpson CA, Huang J, Roth DL, Stewart KE. Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South. AIDS Patient Care STDS. 2013;27(5):280–6.CrossRefPubMedPubMedCentral Tucker JA, Simpson CA, Huang J, Roth DL, Stewart KE. Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South. AIDS Patient Care STDS. 2013;27(5):280–6.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Shorey RC, Moore TM, McNulty JK, Stuart GL. Do alcohol and marijuana increase the risk for female dating violence victimization? A prospective daily diary investigation. Psychol Violence. 2016;6(4):509–18.CrossRefPubMed Shorey RC, Moore TM, McNulty JK, Stuart GL. Do alcohol and marijuana increase the risk for female dating violence victimization? A prospective daily diary investigation. Psychol Violence. 2016;6(4):509–18.CrossRefPubMed
51.
Zurück zum Zitat O’Hara RE, Armeli S, Tennen H. Alcohol and cannabis use among college students: substitutes or complements? Addict Behav. 2016;58:1–6.CrossRefPubMed O’Hara RE, Armeli S, Tennen H. Alcohol and cannabis use among college students: substitutes or complements? Addict Behav. 2016;58:1–6.CrossRefPubMed
Metadaten
Titel
Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care
verfasst von
Aaron M. Kipp
Peter F. Rebeiro
Bryan E. Shepherd
Lauren Brinkley-Rubinstein
Megan Turner
Sally Bebawy
Timothy R. Sterling
Todd Hulgan
Publikationsdatum
17.02.2017
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1716-7

Weitere Artikel der Ausgabe 7/2017

AIDS and Behavior 7/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.